High-dose chemotherapy of metastatic breast cancer: A review Journal Article


Authors: Vahdat, L.; Raptis, G.; Fennelly, D.; Crown, J.
Article Title: High-dose chemotherapy of metastatic breast cancer: A review
Abstract: Very-high-dose chemotherapy produces frequent complete responses in patients with metastatic breast cancer. These responses are transient in patients with disease that had relapsed following, or was refractory to, prior conventionally dosed therapy, but when used as first chemotherapy for metastatic disease or as consolidation for patients with responding cancer, a minority achieve durable complete remissions. Improvements in supportive care, especially in hematopoietic support, have resulted in a considerable reduction in the toxicity of this therapy and may allow further intensification through the use of multiple, rapidly cycled courses. © 1995 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
Keywords: cisplatin; doxorubicin; fluorouracil; methotrexate; antineoplastic agent; carboplatin; metastasis; breast cancer; etoposide; cyclophosphamide; stem cell transplantation; hematopoietic stem cell transplantation; breast neoplasms; carmustine; thiotepa; mitoxantrone; neoplasm metastasis; hematopoietic stem cell; human; female; priority journal; article
Journal Title: Cancer Investigation
Volume: 13
Issue: 5
ISSN: 0735-7907
Publisher: Informa Healthcare  
Date Published: 1995-01-01
Start Page: 505
End Page: 510
Language: English
DOI: 10.3109/07357909509024915
PUBMED: 7552818
PROVIDER: scopus
DOI/URL:
Notes: Review -- Export Date: 28 August 2018 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Linda T Vahdat
    43 Vahdat
  2. George   Raptis
    29 Raptis
  3. John Crown
    47 Crown